EBLN3P and colorectal carcinoma: Although our study showed that EBLN3P acts as an oncogene in CRC, there are several limitations that exist in this study such as limited clinical specimens, the function of EBLN3P/miR-323a-3p/UHMK1 axis in CRC in vivo, and the association of EBLN3P and other potential miRNAs.